Cargando…
CYP2D6 Genetic Variation and Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis
BACKGROUND: Antipsychotic-induced weight gain is a contributing factor in the reduced life expectancy reported amongst people with psychotic disorders. CYP2D6 is a liver enzyme involved in the metabolism of many commonly used antipsychotic medications. We investigated if CYP2D6 genetic variation inf...
Autores principales: | Wannasuphoprasit, Yanisa, Andersen, Stig Ejdrup, Arranz, Maria J., Catalan, Rosa, Jurgens, Gesche, Kloosterboer, Sanne Maartje, Rasmussen, Henrik Berg, Bhat, Anjali, Irizar, Haritz, Koller, Dora, Polimanti, Renato, Wang, Baihan, Zartaloudi, Eirini, Austin-Zimmerman, Isabelle, Bramon, Elvira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850377/ https://www.ncbi.nlm.nih.gov/pubmed/35185676 http://dx.doi.org/10.3389/fpsyg.2021.768748 |
Ejemplares similares
-
Associations of antidepressants and antipsychotics with lipid
parameters: Do CYP2C19/CYP2D6 genes play a
role? A UK population-based study
por: Richards-Belle, Alvin, et al.
Publicado: (2023) -
The Influence of CYP2D6 and CYP2C19 Genetic Variation on Diabetes Mellitus Risk in People Taking Antidepressants and Antipsychotics
por: Austin-Zimmerman, Isabelle, et al.
Publicado: (2021) -
Adolescent Verbal Memory as a Psychosis Endophenotype: A Genome-Wide Association Study in an Ancestrally Diverse Sample
por: Wang, Baihan, et al.
Publicado: (2022) -
Is the CYP2D6 Genotype Associated with Antipsychotic-Induced Weight Gain? †
por: Jürgens, Gesche, et al.
Publicado: (2022) -
Neurophysiology in psychosis: The quest for disease biomarkers
por: Wang, Baihan, et al.
Publicado: (2022)